Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
Active, not recruiting · NCT05598151 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors | Advanced or Metastatic Solid Tumors | Active, not recruiting | Phase 1 | 2026-08-12 | NCT05598151 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hanmi Pharmaceutical Company Limited | 15 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 131 |
| Cancer Research SA | Adelaide | Australia | 3 |
| Grampians Health | Ballarat | Australia | 2 |
| Monash Medical Centre | Clayton | Australia | 5 |
| National Cancer Center | Goyang-si | South Korea | 5 |
| Peninsula and Southeast Oncology | Frankston | Australia | 1 |
| Samsung Medical Center | Seoul | South Korea | 170 |
| Seoul National University Bundang Hospital | Seoul | South Korea | 11 |
| Seoul National University Hospital | Seoul | South Korea | 183 |
| The Catholic University of Korea, Seoul St. Mary's Hospital | Seoul | South Korea | 24 |